(R,S)-(3-Hydroxy-2-methyl-2-(phosphonomethoxy)propy)-guanine Triethylammonium Salt

ID: ALA5182963

PubChem CID: 168280858

Max Phase: Preclinical

Molecular Formula: C16H31N6O6P

Molecular Weight: 333.24

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(CO)(Cn1cnc2c(=O)[nH]c(N)nc21)OCP(=O)(O)O.CCN(CC)CC

Standard InChI:  InChI=1S/C10H16N5O6P.C6H15N/c1-10(3-16,21-5-22(18,19)20)2-15-4-12-6-7(15)13-9(11)14-8(6)17;1-4-7(5-2)6-3/h4,16H,2-3,5H2,1H3,(H2,18,19,20)(H3,11,13,14,17);4-6H2,1-3H3

Standard InChI Key:  COBYQEXISMDUIC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 29  0  0  0  0  0  0  0  0999 V2000
   -0.7014   -2.5846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0167   -3.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7349   -2.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4196   -3.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1378   -2.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7014   -1.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4196   -1.3402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3361   -0.3214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6221    0.0918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6221    0.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3361    1.3319    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0543    0.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7683    1.3319    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.7683    0.5052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4823    0.9185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7683    2.1587    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0960    1.3319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8100    0.9185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8977    0.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7036   -0.0751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1168    0.6430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5657    1.2568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8204    2.0418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6305    2.2130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8852    3.0021    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1858    1.5992    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9269    0.8142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4823    0.1962    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6221    1.7453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  1  4  1  0
  4  5  1  0
  1  6  1  0
  6  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  2  0
 10 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 21 27  1  0
 27 28  2  0
 10 29  1  0
M  END

Associated Targets(Human)

HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 2.2.15 (869 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human betaherpesvirus 5 (5122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 3 (4092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 2 (5592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 333.24Molecular Weight (Monoisotopic): 333.0838AlogP: -1.40#Rotatable Bonds: 6
Polar Surface Area: 176.58Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.35CX Basic pKa: 0.36CX LogP: -3.06CX LogD: -5.25
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.40Np Likeness Score: -0.02

References

1. Tan S, Groaz E, Kalkeri R, Ptak R, Korba BE, Herdewijn P..  (2022)  Reshaping an Acyclic Nucleoside Phosphonate into a Selective Anti-hepatitis B Virus Compound.,  65  (13.0): [PMID:35754374] [10.1021/acs.jmedchem.2c00667]

Source